Barry Quart, Pharm.D. is President, Chief Executive Officer and Director of Heron Therapeutics. Dr. Quart has more than 25 years of experience serving in leadership positions in biotechnology and pharmaceutical companies and developing innovative pharmaceutical products. He holds 18 US patents for pharmaceutical products including drugs for cancer, diarrhea, and gout, with a number of pending patent applications related to postoperative pain. Dr. Quart received a Pharm.D. degree from the University of CA, San Francisco.